These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27884799)

  • 21. Intravenous infection of virulent shigellae causes fulminant hepatitis in mice.
    Martino MC; Rossi G; Tattoli I; Martini I; Chiavolini D; Cortese G; Pozzi G; Bernardini ML
    Cell Microbiol; 2005 Jan; 7(1):115-27. PubMed ID: 15617528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Enteric Defensin 5 Promotes
    Xu D; Liao C; Xiao J; Fang K; Zhang W; Yuan W; Lu W
    Infect Immun; 2019 Dec; 88(1):. PubMed ID: 31611271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Etiological factors in bacillary dysentery in Poland 1965-1979].
    Stypułkowska-Misiurewicz H; Adonajło A
    Przegl Epidemiol; 1981; 35(4):443-53. PubMed ID: 7041196
    [No Abstract]   [Full Text] [Related]  

  • 24. Optimization of virulence functions through glucosylation of Shigella LPS.
    West NP; Sansonetti P; Mounier J; Exley RM; Parsot C; Guadagnini S; Prévost MC; Prochnicka-Chalufour A; Delepierre M; Tanguy M; Tang CM
    Science; 2005 Feb; 307(5713):1313-7. PubMed ID: 15731456
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular genetics of virulence in Shigella.
    Binns MM
    Microbiol Sci; 1985 Sep; 2(9):275-8. PubMed ID: 2484669
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Willis AR; Torraca V; Gomes MC; Shelley J; Mazon-Moya M; Filloux A; Lo Celso C; Mostowy S
    mBio; 2018 Jun; 9(3):. PubMed ID: 29946048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Penetration of Shigella into the epithelial cells as an important condition for the possible appearance of an infectious process].
    Petrovskaia VG
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Sep; (9):24-8. PubMed ID: 4216216
    [No Abstract]   [Full Text] [Related]  

  • 28. Interactions between Shigella flexneri and the Autophagy Machinery.
    Krokowski S; Mostowy S
    Front Cell Infect Microbiol; 2016; 6():17. PubMed ID: 26904515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shigellosis: innate mechanisms of inflammatory destruction of the intestinal epithelium, adaptive immune response, and vaccine development.
    Phalipon A; Sansonetti PJ
    Crit Rev Immunol; 2003; 23(5-6):371-401. PubMed ID: 15030306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inside story of Shigella invasion of intestinal epithelial cells.
    Carayol N; Tran Van Nhieu G
    Cold Spring Harb Perspect Med; 2013 Oct; 3(10):a016717. PubMed ID: 24086068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molecular evolutionary history of Shigella spp. and enteroinvasive Escherichia coli.
    Peng J; Yang J; Jin Q
    Infect Genet Evol; 2009 Jan; 9(1):147-52. PubMed ID: 19000785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunosuppressive properties of virulent Shigella strains].
    Borisova EB
    Mikrobiol Z; 2000; 62(1):64-72. PubMed ID: 11300086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of "intracellular parasitism" in experimental Shigella cystitis.
    Tenner C; Rácz P; Serény B
    Acta Microbiol Acad Sci Hung; 1971; 18(3):179-89. PubMed ID: 4949073
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunization of Mice with a Live Transconjugant Shigella Hybrid Strain Induced Th1 and Th17 Cell-Mediated Immune Responses and Confirmed Passive Protection Against Heterologous Shigellae.
    Nag D; Koley H; Sinha R; Mukherjee P; Sarkar C; Withey JH; Gachhui R
    Scand J Immunol; 2016 Feb; 83(2):92-101. PubMed ID: 26478541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytosolic Access of Intracellular Bacterial Pathogens: The Shigella Paradigm.
    Mellouk N; Enninga J
    Front Cell Infect Microbiol; 2016; 6():35. PubMed ID: 27092296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Type three secretion system and pathogenesis of Shigella spp.--a review].
    Zhu L; Wang H
    Wei Sheng Wu Xue Bao; 2010 Nov; 50(11):1446-51. PubMed ID: 21268888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Live-attenuated Shigella vaccines.
    Venkatesan MM; Ranallo RT
    Expert Rev Vaccines; 2006 Oct; 5(5):669-86. PubMed ID: 17181440
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Genetic basis of the virulence of dysentery bacteria].
    Petrovskaia VG; Bondarenko VM
    Vestn Akad Med Nauk SSSR; 1985; (10):7-14. PubMed ID: 4082760
    [No Abstract]   [Full Text] [Related]  

  • 39. An update on Shigella vaccines.
    Ashkenazi S; Cohen D
    Isr J Med Sci; 1994; 30(5-6):495-7. PubMed ID: 8034510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The role of antibiotic-resistance of Shigella in the epidemiology of dysentery (literature review)].
    Popovich GG; Bondarenko VI
    Vrach Delo; 1983 Aug; (8):111-5. PubMed ID: 6356591
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.